ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1368	National Cancer Institute	Html	en	Breast Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for breast cancer.	Breast Screening Study-2 0.614803 breast cancer deaths 0.621624 widespread mammography screening 0.607903 biennial screening mammography 0.591767 breast cancer case 0.582361 Mammography screening rates 0.59827 meaningful breast cancer 0.581856 breast biopsy 0.585064 Breast Screening Study 0.610161 digital mammography 0.665528 breast screening 0.639247 mammography 0.707944 film mammography 0.596868 Canadian National Breast 0.584048 Nijmegen breast cancer 0.583392 breast cancer treatment 0.611216 Natl Cancer Inst 0.587118 mammography service screening 0.585616 reduces breast cancer 0.583893 Breast Cancer Diagnosis 0.59888 breast cancer therapy 0.585682 invasive breast cancer 0.614887 breast tomosynthesis screening 0.597792 women 0.639036 National Breast Screening 0.627397	early breast cancer 0.585311 increases breast cancer 0.597473 breast cancer detection 0.615948 Breast Screening Program 0.60752 breast cancer die 0.596834 late-stage breast cancer 0.587879 significant breast cancer 0.583394 breast cancers 0.586001 Digital Screening Mammography 0.598927 mammography screening 0.623635 screening mammography 0.613991 Mammography Screening Effectiveness 0.588634 digital breast tomosynthesis 0.604618 UK breast screening 0.596293 breast cancer screening 0.748635 breast cancer risk 0.584885 reduced breast cancer 0.582941 breast cancer 0.993291 clinical breast examination 0.595498 breast cancer mortality 0.853194 breast cancer cases 0.601413 breast cancer mortality. 0.607032 full-field digital mammography 0.586893 breast cancer incidence 0.622797	CLICK HERE
1687	National Cancer Institute	Html	en	Gastrointestinal Stromal Tumors Treatment (PDQ®)–Patient Version	Gastrointestinal stromal tumors (GIST) are usually found on the stomach or small intestine, but they can be found anywhere in or near the GI tract. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for gastrointestinal stromal tumors.	currently used treatment 0.490034 treatment 0.783421 cancer treatment 0.523117 magnetic resonance imaging 0.511967 new cancer treatments 0.495454 gastrointestinal stromal tumors 0.803015 cancer cells 0.659955 cancer spreads 0.50304 body 0.629918 imatinib mesylate 0.539824 Cancer Information Service 0.497222 treatment clinical trial 0.508389 PDQ cancer information 0.611396 specific cancer cells 0.500865 tyrosine kinase inhibitors 0.510959 treatment clinical trials 0.542788 National Cancer Institute 0.565368 clinical trials 0.968461 GISTs 0.508373 GI tract 0.557476 cancer information summary 0.563972 new treatment 0.580544 detailed pictures 0.514969 patients 0.508785	Blood. The cancer 0.489451 metastatic tumor 0.505075 following tests 0.492889 nuclear magnetic resonance 0.514044 PDQ summary 0.507052 Stromal Tumors Treatment 0.504624 PDQ Adult Treatment 0.502889 clinical trial 0.717659 malignant tumor cells 0.539522 NCI PDQ cancer 0.516596 cancer research process 0.486456 cancer clinical trials 0.513219 gastrointestinal stromal tumor 0.560708 supportive care 0.528752 Treatment Editorial Board 0.52414 treatment options 0.517296 cancer information summaries 0.495697 comprehensive cancer information 0.495617 parts 0.488573 cancer 0.897871 standard treatment 0.510757 small intestine 0.49775 watchful waiting 0.49459	CLICK HERE
1801	National Cancer Institute	Html	es	Complicaciones orales de la quimioterapia y la radioterapia a la cabeza y el cuello (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las complicaciones orales, como la mucositis y la disfunción de la glándula salival, que se presentan en pacientes de cáncer tratados con quimioterapia y radioterapia dirigida a la cabeza y el cuello.	InfeccionesEl daño 0.516009 cáncer ayuda 0.542989 siguientes procedimientos 0.51571 células madre 0.946823 suficiente saliva 0.554388 siguientes aspectos 0.527241 sufrirán complicaciones 0.51807 siguientes elementos 0.511604 DolorEl dolor 0.547072 siguientes estrategias 0.509712 largo plazo 0.513745 Cuidado oral habitualLa 0.550733 larga duración 0.545057 efectos tardíos 0.529838 gustoLos cambios 0.518758 Saliva espesa 0.510761 dentaduras postizas 0.776994 siguientes acciones 0.53637 suficiente anticipación 0.516532 tumores benignos 0.514751	alto contenido 0.512147 PDQ Acupuntura 0.508298 dolor ayuda 0.565203 cáncer causa dolor 0.558791 paciente fuma 0.505531 siguientes problemas 0.576848 siguientes causas 0.527818 oralLa mucositis 0.525968 PDQ Fatiga 0.505245 dientes semanas 0.528906 corto plazo 0.543137 paciente trabaje 0.515322 siguientes complicaciones 0.575792 dental completo.Su odontólogo 0.538171 estrecha vigilancia 0.51193 tragarEl dolor 0.544711 rellenos dentales flojos 0.537219 paciente enfrenta situaciones 0.507967 Boca secaLa sequedad 0.620811	CLICK HERE
1972	National Cancer Institute	Html	es	Tratamiento del sarcoma de Kaposi (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de Kaposi.	PDQ Tratamiento 0.421281 estadios tardíos 0.422639 siguientes procedimientos 0.46906 linfocitos cd34 0.430375 Physician Data Query 0.440927 pequeña cantidad 0.415736 Estados Unidos 0.462912 Kaposi causa efectos 0.710153 siguientes tipos 0.434075 vía oral 0.416125 rayos x 0.425639 Kaposi africano 0.971754	enlace drugs approved 0.48088 células cd34 0.490481 siguientes formas 0.418075 vías respiratorias 0.427366 Kaposi Sarcoma 0.792161 estudio clínico 0.421218 National Cancer Institute 0.409422 terapia tarc 0.47747 siguientes riesgos 0.407053 siguientes pruebas 0.484334 Instituto Nacional 0.419362	CLICK HERE
2020	National Cancer Institute	Html	es	Prevención del cáncer de cuello uterino (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre los factores que aumentarían el riesgo de presentar cáncer de cuello uterino y los enfoques que ayudarían a la prevención de esta enfermedad.	cervical intra-epithelial neoplasia 0.302624 Obstet Gynecol 0.303555 Lancet Infect Dis 0.302739 vacuna qHPV 0.302144 VPH vs 0.303877 cervical carcinoma 0.305011 cáncer invasor 0.318393 González A 0.303459 VPH oncógenos 0.304066 American Cancer Society 0.303348 case-control study 0.30305 Costa Rica Vaccine 0.302774 cervical neoplasia 0.303702 Schiffman M 0.30246 without cervical carcinoma 0.302609 risk factors 0.303566 collaborative reanalysis 0.305986 International Collaboration 0.302415 Estados Unidos 0.303742 vacuna 9vHPV 0.303595 cancer in 0.308272 Natl Cancer Inst 0.304144 cervical cancer 0.371053 vacuna vph 0.305378 North American multicohort 0.3021	9-valent hpv vaccine 0.303034 VPH Población Estimación 0.304092 Quadrivalent HPV Vaccination 0.302755 human papillomavirus 0.353991 vacuna nanovalente vlp 0.302596 risk among hiv-infected 0.30327 Bosch FX 0.30227 Castle PE 0.302445 Muñoz N 0.303856 Costa Rica 0.303541 collaboration prospective study 0.303065 Immune Defic Syndr 0.302422 multicohort collaboration prospective 0.302636 Adverse Pregnancy Outcomes 0.302449 Acquir Immune Defic 0.302422 epidemiological studies 0.313912 with cervical carcinoma 0.302983 vacuna vph-16 l1 0.302668 cervical intraepithelial neoplasia 0.304671 cuello uterino 0.985138 American multicohort collaboration 0.302442 Cancer In young 0.302413 vacuna bivalente tipo 0.302487 cancer risk 0.305603	CLICK HERE
2049	National Cancer Institute	Html	es	Trasplantes de células madre formadoras de sangre	Hoja informativa que explica los procedimientos, paso a paso, del trasplante de médula ósea y del trasplante de células madre de sangre periférica, así como sus riesgos y beneficios.	células madre 0.995824 efecto gvt 0.300369 trasplante autólogo 0.304497 PBSCT alogénicos 0.300755 llamadas antígenos 0.300572 frecuencia células madre 0.306001 bone marrow transplantation 0.300883 raros casos 0.300403 Sin embargo 0.307734 catéter venoso central 0.300806 Programa Nacional 0.300971 llamadas células madre 0.30624 largo plazo 0.300324 causa disminución 0.300351 seguro médico 0.300814	cubre be 0.300325 paciente transfusiones 0.301172 HLA compatibles mejora 0.301344 idéntico.  sin embargo 0.300876 antígenos hla 0.303269 stem cell transplantation 0.300928 programa be 0.300461 posibles efectos 0.301054 linfocitos t".  0.3004 atacan.  más 0.300461 GVHD aguda 0.300451 corto plazo 0.30031 sangre.  solo 0.300435 usa dosis 0.301797 tipo hla 0.300841	CLICK HERE
3430	National Cancer Institute	Html	es	Vitamina D y prevención del cáncer	Hoja informativa que resume los resultados de estudios sobre la vitamina D y la prevención del cáncer. Incluye información acerca de las recomendaciones dietéticas de vitamina D.	or without calcium 0.304559 pre-diagnostic circulating 0.302687 Nomura AM 0.302611 menor incidencia 0.30287 Bueno-de-Mesquita HB 0.302697 Sin embargo 0.347217 vitamina d2 0.359138 vitamina d 0.969991 Working Group Reports 0.305032 Nutrition Examination Survey 0.305408 Dietary Reference Intakes 0.304573 Preventive Services Task 0.304306 Kotchen JM 0.302687 Instituto Nacional 0.302694 Jenab M 0.302565 IARC Working Group 0.325138 estudio vitamin 0.304251 Internal Medicine 0.302749 nested case-control study 0.304876 Calcium plus 0.302727 vitamina d3 0.358882 rayos ultravioleta 0.302804 Academias Nacionales 0.302714 PubMed Abstract 0.415835 omega-3 trial 0.309613	updated meta-analysis 0.302703 Clinical Oncology 0.303267 International Journal 0.302591 cohort study 0.30307 vitamin d 0.319766 Contemporary Clinical Trials 0.305104 Endocrine-Related Cancer 0.30602 Numerosos estudios 0.304406 luz solar 0.307463 alto consumo 0.305055 primary prevention 0.303006 large randomized controlled 0.30456 siguientes consumos 0.303025 Yetley EA 0.302569 Woolcott CG 0.302657 Clinical Nutrition 0.303564 consumos dietéticos promedio 0.306519 systematic review 0.302703 Larriba MJ 0.302545 Women’s Health Initiative 0.30465 Wilkens LR 0.302784 suficiente vitamina d 0.340884 New England Journal 0.304545 Brulé D 0.306623	CLICK HERE
3441	National Cancer Institute	Html	es	Exámenes de detección del neuroblastoma (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el neuroblastoma.	Berthold F 0.326193 mass screening 0.922436 Tuchman M 0.34781 Children may not 0.324022 neuroblastoma mortality 0.351312 Woods WG 0.492877 localized neuroblastoma detected 0.404842 Parker L 0.323694 may not benefit 0.324348 Cancer Screening 0.425638 chemical screening 0.340948 Yamamoto K 0.365979 benefit from neuroblastoma 0.405641 through mass screening 0.347656 PDQ Exámenes 0.326687 Hanada R 0.340494 mass screening system 0.350977 with neuroblastoma detected 0.349391 mass screening program 0.35097 Chamberlain J 0.321084 not benefit from 0.325375 Schilling FH 0.328231 Matsumura T 0.318421 German Neuroblastoma Screening 0.39432 with neuroblastoma 0.385081	Oncology Group study 0.324277 Neuroblastoma Cooperative Study 0.352151 Kluwer Academic Publishers 0.324031 childhood neuroblastoma death 0.391312 urinary mass screening 0.348636 Neuroblastoma mass screening 0.390256 neuroblastoma through mass 0.359101 Quebec Neuroblastoma Screening 0.468726 neuroblastoma detected 0.476634 from neuroblastoma screening 0.464226 childhood neuroblastoma 0.424072 Pediatr Hematol Oncol 0.393544 Med Pediatr Oncol 0.517922 Clin Oncol 0.429185 Neuroblastoma trends 0.350168 neuroblastoma without 0.349525 or metastatic neuroblastoma 0.348237 for screening 0.34682 Takeda T 0.332537 Pediatric Oncology Group 0.318607 Spix C 0.326336 Neuroblastoma Screening Project 0.535562 neuroblastomas detected through 0.332839 neuroblastoma screening 0.923332	CLICK HERE
16651	National Cancer Institute	Html	en	Current and Alumni Fellows	NCI and FDA collaborate to train scientists in research and research-related regulatory review. Meet the current IOTF fellows.	different manufacturing methods 0.665313 product quality research/review 0.827177 hematopoietic stem cell 0.710973 cancer signal transduction 0.668322 Doctoral degree 0.684206 product quality 0.918183 challenging supervisory roles 0.648276 Oncology Task Force 0.8356 oncology drug products 0.690726 long term goal 0.660419 Review Team Leader 0.655657 Biological Sciences 0.682061 gene therapy products 0.670826 new therapeutic targets 0.828038 DNA repair proteins 0.657265 Dr. Sanduja 0.871474 overall research 0.68067 invaluable training experience 0.676806 NCI-FDA Interagency Oncology 0.711009 oncology product research 0.767652 drug development process 0.675006 cell therapy products 0.686143 experienced product quality 0.672111 Mixed Lineage Leukemia 0.669398 intramural FDA training/courses 0.684636	various FDA centers 0.683563 regulatory sciences 0.680019 NCI-NIH-FDA Interagency Oncology 0.692697 post-doctoral training 0.683105 mesenchymal stromal cells 0.685647 breast cancer metastasis 0.669833 product quality reviewer 0.814583 South Carolina 0.648309 IOTF fellowship 0.939794 current fellows 0.684819 acute myeloid leukemia 0.671421 Task Force Fellowship 0.822403 full-time product quality 0.810197 oncology research experience 0.714771 National Cancer Institute 0.698441 cancer stem cells 0.955681 Interagency Oncology Task 0.843679 mammary stem cell 0.68776 quality research/review fellow 0.82871 breast cancer stem 0.695251 Dr. Ergen 0.910594 Jawaharlal Nehru University 0.669149 pre-clinical cancer models 0.702445 national regulatory conferences 0.67238	CLICK HERE
17282	National Cancer Institute	Html	es	Opciones para su atención médica si el tratamiento puede no ser una opción	Diferentes pacientes tienen metas de atención diferentes. Evalúe sus opciones de atención médica una vez se entere que tiene cáncer avanzado.	experta atención 0.942071 Palliative Care Organization 0.880871 situación mejora 0.828197	corto plazo 0.853503 sentimientos frente 0.970266	CLICK HERE